Techne Corporation (TECH)
Create an AlertTECH Key Stats
| Income Statement | |
| Revenue TTM | 312.41M |
| Revenue Quarterly YoY Growth | 0.56% |
| EPS Diluted TTM | 2.988 |
| EPS Diluted Quarterly YoY Growth | -1.43% |
| Net Income TTM | 110.03M |
| Profitability | |
| Gross Profit Margin Quarterly | 73.60% |
| Profit Margin Quarterly | 33.78% |
| Dividend | |
| Dividend Yield | 1.76% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 2.509B |
| Enterprise Value | 2.227B |
| PE Ratio TTM | 22.79 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.612 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | 23.07M |
| Return on Equity | 16.71% |
TECH News
- Will Techne Whiff on Revenues Next Quarter? Fool Jun 19
- Techne to Acquire Diagnostics Firm for $104 Million Fool Jun 18
- Techne to buy Bionostics for $104M in cash Jun 18
- TECHNE CORP /MN/ Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jun 18
- Techne Corp (TECH) Acquries Bionostics Street Insider Jun 18
- Techne Corporation Announces Acquisition Agreement PR Newswire Jun 18
- Techne Corporation Moves Up In Market Cap Rank, Passing Apollo Group Jun 12
- Can New Management Drive New Growth At Techne? Jun 11
- Why Techne May Be About to Take Off Fool Jun 11
- Harvard Online Venture EdX Grows to 27 Universities Adding Asia May 21
TECH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Techne Corporation is up 1.13% over the last year vs S&P 500 Total Return up 23.89%, Abiomed up 1.75%, and Solei Systems down 22.22%.
TECH Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these TECH related companies
Pro Ratings for TECH
Pro Report PDF for TECH
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TECH Pro Report PDF
Pro Strategies Featuring TECH
Did Techne Corporation make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
TECH Profile
Sector: Healthcare
Industry: Medical Devices
TECHNE Corporation, incorporated in Minnesota in 1981, is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (RDSE) located in Abingdon, England. Over 95% of TECHNE's revenues are derived from products developed and manufactured in-house. R&D Systems is a specialty manufacturer of biological products. It has two operating divisions: Hematology and Biotechnology. RDSE sells and distributes the Company's biotechnology products throughout Europe and parts of Asia and Africa.
Other TECH Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TECH | 68.10 | -0.11 | -0.16% | 2.509B |
